Table 1 |
|||||
|
Baseline characteristics of the study population by group |
|||||
|
RSV+Fib |
RSV |
SIM/EZE+Fib |
SIM+EZE |
P-value |
|
|
N = 28 |
N = 30 |
N = 28 |
n = 30 |
||
|
|
|||||
|
Age, years1 |
57 (1) |
60 (2) |
62 (1) |
58 (1) |
0.21 |
|
Female, n (%)2 |
21 (75) |
20 (67) |
19 (68) |
22 (73) |
0.87 |
|
Hypertension, n (%)2 |
22 (79) |
24 (80) |
18 (64) |
26 (87) |
0.22 |
|
Diabetes, n (%)2 |
5 (18) |
7 (23) |
6 (21) |
9 (30) |
0.73 |
|
Smoking, n (%)2 |
2 (7) |
3 (10) |
1 (4) |
2 (7) |
0.82 |
|
Metabolic Syndrome, n (%)2 |
17 (61) |
18 (60) |
13 (46) |
14 (47) |
0.53 |
|
|
|||||
|
Differences between groups were analyzed by ANOVA1, or Pearson's chi-square test2. RSV = rosuvastatin; Fib = fiber; SIM = simvastatin; EZE = ezetimibe. |
|||||
|
Ramos et al. Nutrition Journal 2011 10:80 doi:10.1186/1475-2891-10-80 |
|||||
